HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Corporate Insurer Projects Increased Liability For ‘Toxic Trio’ Use In Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Allianz Global Corporate and Specialty raises liability concerns that could be relevant to cosmetics manufacturers still using “toxic trio” ingredients. The firm’s report is a signal at least that rampant US litigation for alleged false advertising and undeclared ingredient risks has reached the international insurance consciousness.

You may also be interested in...



California DTSC Selects Toluene In Nail Care For Potential Phase-Out

The proposal under the state’s Safer Consumer Products regulation marks the ingredient for alternative analyses and potential replacement in nail-care products. California’s Department of Toxic Substances Control cites possible dangers to salon workers in particular, including nervous system, respiratory and developmental toxicity risks.

Nail Polishes Contain Undeclared DEHP, Among Other ‘Regrettable Substitutions’ – Study

A study led by Harvard public health researchers explores a multipart question: If dibutyl phthalate has been phased out of nail polishes, what plasticizers are replacing the ingredient, are they labeled or otherwise declared, and are they any safer than DBP?

J&J Hopes To Continue Appellate Streak Following Whopping $4.69bn Talc Verdict

Counsel for 22 women who blame J&J talcum powders for their ovarian cancer took a new approach in this latest case in St. Louis Circuit Court, arguing that asbestos in the firm’s talc is the culprit, rather than talc itself. J&J is confident in its ability to overturn the verdict, which it characterized as biased and unfounded.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel